Clinical Trials
6
Active:0
Completed:3
Trial Phases
3 Phases
Phase 2:1
Phase 4:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 2
1 (25.0%)Phase 4
1 (25.0%)Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )
Phase 2
Recruiting
- Conditions
- Ischemic Stroke, Acute
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Yongjun Wang
- Target Recruit Count
- 100
- Registration Number
- NCT06492265
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients
- Conditions
- StrokeAtrial Fibrillation
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2014-06-05
- Lead Sponsor
- yongjun wang
- Target Recruit Count
- 3000
- Registration Number
- NCT02156765
- Locations
- 🇨🇳
Beijing Stroke Association, Beijing, Beijing, China
Affect of Multiple Health Education on Medication Persistence and Clinical Prognosis of Ischemic Stroke Patients
Not Applicable
Completed
- Conditions
- Medication PersistenceIschemic Stroke
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- yongjun wang
- Target Recruit Count
- 3111
- Registration Number
- NCT02140619
- Locations
- 🇨🇳
Beijing Tian Tan Hospital, Capital Medical University, Beijing, Beijing, China
Affect of Health Education on Statins Medication Persistence and ClinicaL Prognosis of Ischemic Stroke Patients (HELP)
Not Applicable
Completed
- Conditions
- Ischemic Stroke
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- yongjun wang
- Target Recruit Count
- 3111
- Registration Number
- NCT02140658
- Locations
- 🇨🇳
Beijing Tian Tan Hospital, Capital Medical University, Beijing, China
Tongxinluo Capsule in Ischemic Stroke Patients（TISS)
Phase 4
Completed
- Conditions
- Ischemic Stroke
- Interventions
- Drug: Tongxinluo capsuleDrug: placebo capsule
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- yongjun wang
- Target Recruit Count
- 2007
- Registration Number
- NCT01919671
- Locations
- 🇨🇳
Beijing TianTan Hospital,Capital Medical University, Beijing, China
- Prev
- 1
- 2
- Next
News
No news found